WHO halts hydroxychloroquine trial in COVID-19 following safety concernsThe World Health Organisation has halted clinical tests of hydroxychloroquine against COVID-19, after safety concerns emerged in a Share XWHO halts hydroxychloroquine trial in COVID-19 following safety concernshttps://pharmaphorum.com/news/who-halts-hydroxychloroquine-trial-in-covid-19-following-safety-concerns/
Novavax gets $384m for clinical trial of COVID-19 vaccineGlobal vaccine development organisation CEPI is to invest $384 million additional funding in a COVID-19 jab being developed Share XNovavax gets $384m for clinical trial of COVID-19 vaccinehttps://pharmaphorum.com/news/novavax-gets-384m-for-clinical-trial-of-covid-19-vaccine/
Has pharma been too slow to respond to coronavirus?The new coronavirus strain emerging in China is making headlines across the world, with the disease sending entire Share XHas pharma been too slow to respond to coronavirus?https://pharmaphorum.com/r-d/views-analysis-r-d/has-pharma-been-too-slow-to-respond-to-coronavirus/
WHO criticises lack of big pharma antibiotic R&DBig pharma still continues to look upon antibiotic resistance as somebody else’s problem, the World Health Organization has Share XWHO criticises lack of big pharma antibiotic R&Dhttps://pharmaphorum.com/news/who-bemoans-lack-of-big-pharma-antibiotic-rd/
WHO to support digital health expansion, while tackling governance issuesThe World Health Organization’s director general has pledged to support countries to maximise the benefits of digital health, Share XWHO to support digital health expansion, while tackling governance issueshttps://pharmaphorum.com/news/who-to-support-digital-health-expansion-while-tackling-governance-issues/
First effective Ebola treatment a step closer after breakthrough trialClinical trials of four experimental treatments for Ebola in the Congo have been halted early after two of Share XFirst effective Ebola treatment a step closer after breakthrough trialhttps://pharmaphorum.com/news/ebola-virus-clinical-trial-breakthrough/
Digital health goes global and continues to grow upHow to deal with new and emerging technologies is an ongoing problem for healthcare stakeholders, who often struggle Share XDigital health goes global and continues to grow uphttps://pharmaphorum.com/digital/digital-health-guidelines-growth/
WHO releases first guidelines on digital healthThe World Health Organization (WHO) has released new recommendations on ways that countries can use digital health technology Share XWHO releases first guidelines on digital healthhttps://pharmaphorum.com/news/who-releases-first-guidelines-on-digital-health/
How to fix your adherence problemTypical patient support programs fail to improve adherence – and it’s costing the pharma industry billions. Here’s how Share XHow to fix your adherence problemhttps://pharmaphorum.com/partner-content-patients/fix-adherence-problem/
